Literature DB >> 15042221

Malaria vaccines: lessons from field trials.

C J Struchiner1, M E Halloran, R C Brunet, J M Ribeiro, E Massad.   

Abstract

Malaria vaccine candidates have already been tested and new trials are being carried out. We present a brief description of specific issues of validity that are relevant when assessing vaccine efficacy in the field and illustrate how the application of these principles might improve our interpretation of the data being gathered in actual malaria vaccine field trials. Our discussion assumes that vaccine evaluation shares the same general principles of validity with epidemiologic causal inference, i.e., the process of drawing inferences from epidemiologic data aiming at the identification of causes of diseases. Judicious exercise of these principles indicates that, for meaningful interpretation, measures of vaccine efficacy require definitions based upon arguments conditional on the amount of exposure to infection, and specification of the initial and final states in which one believes the effect of interest takes place.

Entities:  

Year:  2004        PMID: 15042221     DOI: 10.1590/s0102-311x1994000800009

Source DB:  PubMed          Journal:  Cad Saude Publica        ISSN: 0102-311X            Impact factor:   1.632


  6 in total

1.  Randomization and baseline transmission in vaccine field trials.

Authors:  C J Struchiner; M E Halloran
Journal:  Epidemiol Infect       Date:  2007-02       Impact factor: 2.451

2.  Estimating strain-specific and overall efficacy of polyvalent vaccines against recurrent pathogens from a cross-sectional study.

Authors:  Kari Auranen; Hanna Rinta-Kokko; M Elizabeth Halloran
Journal:  Biometrics       Date:  2013-02-04       Impact factor: 2.571

3.  Simulations for designing and interpreting intervention trials in infectious diseases.

Authors:  M Elizabeth Halloran; Kari Auranen; Sarah Baird; Nicole E Basta; Steven E Bellan; Ron Brookmeyer; Ben S Cooper; Victor DeGruttola; James P Hughes; Justin Lessler; Eric T Lofgren; Ira M Longini; Jukka-Pekka Onnela; Berk Özler; George R Seage; Thomas A Smith; Alessandro Vespignani; Emilia Vynnycky; Marc Lipsitch
Journal:  BMC Med       Date:  2017-12-29       Impact factor: 8.775

4.  Challenges of evaluating and modelling vaccination in emerging infectious diseases.

Authors:  Zachary J Madewell; Natalie E Dean; Jesse A Berlin; Paul M Coplan; Kourtney J Davis; Claudio J Struchiner; M Elizabeth Halloran
Journal:  Epidemics       Date:  2021-10-05       Impact factor: 5.324

5.  Estimation of vaccine efficacy in a repeated measures study under heterogeneity of exposure or susceptibility to infection.

Authors:  Clarissa Valim; Maura Mezzetti; James Maguire; Margarita Urdaneta; David Wypij
Journal:  Philos Trans A Math Phys Eng Sci       Date:  2008-07-13       Impact factor: 4.226

6.  Targeted screening strategies to detect Trypanosoma cruzi infection in children.

Authors:  Michael Z Levy; Vivian Kawai; Natalie M Bowman; Lance A Waller; Lilia Cabrera; Viviana V Pinedo-Cancino; Amy E Seitz; Frank J Steurer; Juan G Cornejo del Carpio; Eleazar Cordova-Benzaquen; James H Maguire; Robert H Gilman; Caryn Bern
Journal:  PLoS Negl Trop Dis       Date:  2007-12-26
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.